Background: Casein phosphopeptide–amorphous calcium phosphate is a biomimetic remineralizing agent but is unsuitable for individuals with a milk‐protein allergy. This exploratory ex vivo study compared low‐concentration slurries containing mineralization‐promoting peptide‐3, sodium fluoride plus mineralization‐promoting peptide‐3, vehicle cream or casein phosphopeptide–amorphous calcium phosphate on demineralized enamel. Methods: Forty‐eight permanent molars were randomly allocated to four groups. Formulations were applied as 0.1% weight/volume slurries once daily for 10 days after 28‐day pH cycling. Surface microhardness was measured at baseline, after demineralization and on Days 5 and 10. Micro‐computed tomography grey‐level units were assessed at baseline, after demineralization and on Day 5. Between‐group comparisons used surface microhardness change and percentage recovery. Results: No significant between‐group differences were detected for surface microhardness change on Day 5 ( p = 0.126) or Day 10 ( p = 0.412), or for percentage recovery on Day 5 ( p = 0.543) or Day 10 ( p = 0.406). All groups showed significant recovery from post‐demineralization to Day 10. Grey‐level units increased descriptively in all groups by Day 5. Conclusions: Under this low‐concentration model, all formulations produced partial surface microhardness recovery without evidence of differential efficacy. The findings are exploratory and do not demonstrate equivalence or clinical effectiveness.
Background: Prefabricated zirconia crowns are used to restore extensively damaged primary incisors, including in children undergoing comprehensive dental treatment under general anesthesia. Clinical documentation of the types and timing of subsequent restoration-related complications is useful, but follow-up ascertainment must be considered when interpreting event frequencies. Objective: To describe recorded failure types and their timing among prefabricated zirconia crowns placed after pulpectomy on maxillary primary central and lateral incisors in children treated under general anesthesia. Methods: In this retrospective chart review, 113 patient records were screened. Two records contained no documented maxillary primary incisor crowns, and two further records were excluded in full because their tooth-group counts exceeded the anatomically possible number of maxillary primary incisors and could not be reconciled with source charts. The resulting analysis dataset comprised 109 children with 396 recorded eligible maxillary primary incisor crowns (205 central and 191 lateral). All included teeth underwent pulpectomy before crown placement. Documented debonding and trauma-related loss of the tooth–crown complex were distinguished. Individual dates of event-free review and censoring were unavailable, precluding valid Kaplan–Meier analysis. Results: After excluding two records with no documented eligible incisor crown and two records with irreconcilable tooth-count inconsistencies, the revised analysis includes 109 children and 396 recorded maxillary primary incisor crowns (205 central and 191 lateral). There were 48 girls and 61 boys. Five documented failures occurred within 18 months (three debondings and two trauma-related events), and two additional events occurred at 41 and 49 months. These frequencies do not establish a fixed-time risk or survival estimate. Conclusions: The available clinical records identified loss of crown retention and traumatic injury to the restored tooth–crown complex as distinct documented failure modes after zirconia crown placement on pulpectomized maxillary primary incisors. Incomplete restoration-specific follow-up records preclude reliable estimation of crown survival or cumulative failure risk. Prospective restoration-level follow-up is needed to quantify longevity.